Hiscox Ltd Stock London S.E.
Equities
HSX
BMG4593F1041
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.94B | Sales 2025 * | 4.27B 5.42B | Capitalization | 3.94B 5B |
---|---|---|---|---|---|
Net income 2024 * | 466M 592M | Net income 2025 * | 500M 635M | EV / Sales 2024 * | 1.14 x |
Net Debt 2024 * | 513M 651M | Net Debt 2025 * | 513M 651M | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
8.46
x | P/E ratio 2025 * |
7.76
x | Employees | - |
Yield 2024 * |
2.79% | Yield 2025 * |
3.1% | Free-Float | 97.41% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Jonathan Bloomer
CHM | Chairman | 70 | 23-05-31 |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
1st Jan change | Capi. | |
---|---|---|
+58.32% | 68.15B | |
+12.21% | 50.45B | |
+11.79% | 48.76B | |
+17.92% | 43.56B | |
+35.41% | 37.61B | |
+71.69% | 31.77B | |
+12.11% | 29.63B | |
+27.75% | 25.69B | |
+1.19% | 21.91B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock